FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Right Issue Status: Closed [5th Aug 2022 to 19th Aug 2022]
Gennex Laboratories Limited Right Issue of Rs 37.95 Cr opens for subscription from August 05 to August 19, 2022. The company issues 1 right equity shares for every 2 fully paid-up equity share held on the record date, 22 July, 2022. The face value of a share is Rs. 1 per share and the right issue price is fixed at Rs. 6 per share with Rs 5 as premium per share. Stay updated with us to know more about the Gennex Laboratories Right Issue Details 2022 including issue size, right issue entitlement, terms of payment, and more.
The company aims to raise funds from the right issue towards the following objectives:
Gennex Laboratories Issue Details | Values |
---|---|
Category | RightIssue |
Right Issue Issue Size (Shares) | 6.32 Cr |
Right Issue Issue Size (Amount) | ₹37.95 Cr |
Face Value | ₹1 Per Equity Share |
Right Issue - Issue Price | ₹6 per share |
Right Issue Record Date | 22nd Jul 2022 |
Right Issue Entitlement | 1 Rights Equity Share for every 2 Equity Shares held on the Record Date |
Right Issue Terms of payment | ₹1.50/- per Equity Shares to be paid on application and remaining ₹4.50/- per on First and Final Call. |
Listing At | BSE |
BSE Code | 531739 |
NSE Code |
In this section we have covered all important dates related to Gennex Laboratories Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
Right Issue Activity | Date |
---|---|
Right Issue Issue Open Date | 5th Aug 2022 |
Right Issue Issue Close Date | 19th Aug 2022 |
Basis of Allotment Finalisation Date* | 25th Aug 2022 |
Refunds Initiation* | 26th Aug 2022 |
Credit of Shares to Demat Account* | 31st Aug 2022 |
Right Issue Listing Date* | 2nd Sep 2022 |
* - Tentative Dates
Zerodha Trade@20
Incorporated in the year 1995, Gennex Laboratories Ltd is a Pharmaceutical Ingredient Manufacturer located in Bollaram Industrial Area. The company product segment includes Expectorants, Muscle Relaxants, Analgesic, and Anti Fungal medicines. Its major business comes from exports in more than 50 countries across 5 continents.
The company has been providing services in the Indian market for the past 20 years. It is ready to set up another facility in Hyderabad with Major Regulatory Market approvals such as USFDA, COFEPRIS, TGA, and EDQM.
Past performance and financial results of Gennex Laboratories.
Gennex Laboratories Financials (₹ in Lakh) | 31-Mar-2022 | 31-Mar-2021 |
---|---|---|
Total Assets | ₹6,820.90 | ₹5,908.44 |
Total Income | ₹6,259.51 | ₹6,017.34 |
Net Profit/Loss | ₹410.54 | ₹403.81 |
The table below is live update of Right Issue bidding details from NSE and BSE.
Gennex Laboratories Right Issue Offer Document (Letter of Offer) >>Document
Gennex Laboratories Right Issue Offer Document (Letter of Offer) >>Gennex Laboratories Right Issue Red Herring Prospectus is not yet available.
Gennex Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Gennex Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Gennex Laboratories Right Issue RTA information is not yet available.
Last Updated on 2022-08-03T00:21:03+00:00